BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 7513276)

  • 1. Chronic hepatitis C.
    Sherlock DS
    Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C: an overview.
    Bhandari BN; Wright TL
    Annu Rev Med; 1995; 46():309-17. PubMed ID: 7598467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C].
    Krarup HB; Krogsgaard K
    Ugeskr Laeger; 1994 Jul; 156(28):4129-34. PubMed ID: 8066908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
    Gordon SC; Kodali VP; Silverman AL; Dmuchowski CF; Urdea MS; Chan CS; Wilber JC
    Am J Gastroenterol; 1994 Sep; 89(9):1458-61. PubMed ID: 8079919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
    Buffet-Janvresse C; Peigue-Lafeuille H; Benichou J; Vabret A; Branger M; Trimoulet P; Goria O; Laurichesse H; Abbed A; Verdon R; Bouvet E; Lafon ME; Dussaix E; Cormerais L; Dupon M; Henquell C; Josse A; Lagoutte P; Lariven S; LeGac S; Riachi G; Verdon R; Vittecoq D;
    J Med Virol; 2003 Jan; 69(1):7-17. PubMed ID: 12436472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Viral hepatitis C].
    Zeuzem S; Roth WK; Herrmann G
    Z Gastroenterol; 1995 Feb; 33(2):117-32. PubMed ID: 7536996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C, awakening of a giant].
    van Hattum J
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):119-24. PubMed ID: 8618627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
    Kwon SY; Ahn MS; Chang HJ
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome of hepatitis C as a function of mode of transmission.
    Gordon SC; Bayati N; Silverman AL
    Hepatology; 1998 Aug; 28(2):562-7. PubMed ID: 9696025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hepatitis C: prevention and treatment.
    Ozaras R; Tahan V
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.
    Pramoolsinsap C; Poovorawan Y; Sura T; Theamboonlers A; Busagorn N; Kurathong S
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers.
    Papatheodoridis GV; Delladetsima J; Verghisi-Nikolakaki S; Malliori M; Krystallis A; Hatzakis A; Tassopoulos NC
    Am J Gastroenterol; 1995 Oct; 90(10):1843-6. PubMed ID: 7572906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.